Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9179095 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
Condition: West Nile Virus
Intervention: Drug: Omr-IgG-am

Study has passed its completion date and status has not been verified in more than two years.